Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer
European Journal of Nuclear Medicine and Molecular Imaging, Volume 34, No. 7, Year 2007